BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 3494798)

  • 1. [Effects of radiotherapy on cellular immunity of patients with head and neck cancers].
    Misaki T; Arai K; Konishi J; Abe M; Torizuka K; Makimoto K; Nesumi N
    Nihon Gan Chiryo Gakkai Shi; 1986 Dec; 21(10):2371-6. PubMed ID: 3494798
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of nonthymic irradiation on cellular immunocompetence.
    Silverman NA; Alexander JC; Potvin C; Chretien PB
    Surg Forum; 1975; 26():345-6. PubMed ID: 1216154
    [No Abstract]   [Full Text] [Related]  

  • 3. A correlative analysis of in vitro parameters of cellular immunity in patients with squamous cell carcinoma of the head and neck.
    Deegan MJ; Coulthard SW; Quaiman SJ; Schork MA
    Cancer Res; 1977 Dec; 37(12):4475-81. PubMed ID: 144562
    [No Abstract]   [Full Text] [Related]  

  • 4. Toll-like Receptors in Regulatory T Cells of Patients With Head and Neck Cancer.
    Wild CA; Brandau S; Lindemann M; Lotfi R; Hoffmann TK; Lang S; Bergmann C
    Arch Otolaryngol Head Neck Surg; 2010 Dec; 136(12):1253-9. PubMed ID: 21173376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship of circulating IgA to cellular immunity in head and neck cancer patients.
    Schantz SP; Liu FJ; Taylor D; Beddingfield N; Weber RS
    Laryngoscope; 1988 Jun; 98(6 Pt 1):671-8. PubMed ID: 3259661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of subsets of lymphocytes infiltrating head and neck tumor tissue: a preliminary report.
    Rabin BS; Johnson J; Claassen D
    Laryngoscope; 1984 May; 94(5 Pt 1):688-90. PubMed ID: 6232437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of T-lymphocytes and delayed cutaneous hypersensitivity reaction in patients with squamous cell carcinoma of head and neck region.
    Singh SN; Agrawal BM; Shanker R; Rajvanshi VS
    Indian J Cancer; 1979; 16(3-4):53-8. PubMed ID: 317272
    [No Abstract]   [Full Text] [Related]  

  • 8. [The immunological prognosis of complications in patients undergoing reconstructive operations after the radiation therapy of malignant tumors of the maxillofacial area and neck].
    Trufanov VD; Boĭkov AN; Simonova AV; Zandelov VL; Kulakov AV
    Stomatologiia (Mosk); 1991; (6):35-7. PubMed ID: 1803649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular immune response in squamous cell carcinomas of head and neck: evaluation by histological indices.
    Ariz M; Ahmad KN; Khan AA; Hasan SA
    Indian J Pathol Microbiol; 1986 Oct; 29(4):392-9. PubMed ID: 3817970
    [No Abstract]   [Full Text] [Related]  

  • 10. Assessment of immunocompetent cells in patients with head and neck squamous cell carcinoma.
    Dawson DE; Everts EC; Vetto RM; Burger DR
    Ann Otol Rhinol Laryngol; 1985; 94(4 Pt 1):342-5. PubMed ID: 3875306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preservation of in vitro biological functions in regional lymph node lymphocytes in squamous head and neck cancer.
    Saxon A; Portaro J
    Cancer Res; 1977 Apr; 37(4):1159-64. PubMed ID: 139203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological status of patients in carcinoma head and neck.
    Vasenwala SM; Aziz M; Rattan A; Ahmad KN
    Indian J Cancer; 1989 Sep; 26(3):137-44. PubMed ID: 2630426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concomitant immunopathology with squamous cell carcinomas of the head and neck regions.
    Berlinger NT; Good RA
    Trans Sect Otolaryngol Am Acad Ophthalmol Otolaryngol; 1976; 82(5):588-94. PubMed ID: 138999
    [No Abstract]   [Full Text] [Related]  

  • 14. [Concurrent carboplatin with radiotherapy in advanced squamous cell carcinoma of the head and neck].
    Fujii M; Kanzaki J
    Gan To Kagaku Ryoho; 1992 Mar; 19(3):391-4. PubMed ID: 1543366
    [No Abstract]   [Full Text] [Related]  

  • 15. Serial studies of immunocompetence in head and neck cancer patients undergoing radiation therapy.
    Stefano S; Kerman R; Abbate J
    AJR Am J Roentgenol; 1976 Apr; 126(4):880-6. PubMed ID: 179361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor antigen phenotype, biologic staging, and prognosis in head and neck squamous carcinoma.
    Wolf GT; Carey TE
    J Natl Cancer Inst Monogr; 1992; (13):67-74. PubMed ID: 1389697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunity indices of patients with locally disseminated malignant neoplasms of the head and neck].
    Bulbuk GA
    Vopr Onkol; 1982; 28(4):57-9. PubMed ID: 7090271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological status in cervical cancer in relation to pelvic irradiation.
    Chandra M; Chander S
    Indian J Med Res; 1986 Oct; 84():413-7. PubMed ID: 3781598
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunological approach in the evaluation of regional lymph nodes of patients with squamous cell carcinoma of the head and neck.
    Verastegui E; Morales R; Barrera JL; Müeller A; Guzman B; Meneses A; Alfaro G
    Clin Immunol; 2002 Jan; 102(1):37-47. PubMed ID: 11781066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-radiotherapy plasma total glutathione is associated to outcome in patients with head and neck squamous cell carcinoma.
    Bøhn SK; Smeland S; Sakhi AK; Thoresen M; Russnes KM; Tausjø J; Svilaas A; Svilaas T; Blomhoff R
    Cancer Lett; 2006 Jul; 238(2):240-7. PubMed ID: 16157445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.